HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47671,
"recordsTotal": 47671,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=title&start=46500",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=title&start=45900",
"results": [
{
"registry_id": "NCT06868238",
"publication_url": "https://clinicaltrials.gov/study/NCT06868238",
"title": "Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219238",
"publication_url": "https://clinicaltrials.gov/study/NCT07219238",
"title": "A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365332",
"publication_url": "https://clinicaltrials.gov/study/NCT07365332",
"title": "An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension (PAH)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inhibikase Therapeutics",
"sponsor_slug": "inhibikase-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284602",
"publication_url": "https://clinicaltrials.gov/study/NCT07284602",
"title": "A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PureTech",
"sponsor_slug": "puretech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258290",
"publication_url": "https://clinicaltrials.gov/study/NCT07258290",
"title": "Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Teleflex",
"sponsor_slug": "teleflex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290439",
"publication_url": "https://clinicaltrials.gov/study/NCT07290439",
"title": "Improving Maternal and Child Health Through Point-of-care STI Testing (MATCH-POINT)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07306364",
"publication_url": "https://clinicaltrials.gov/study/NCT07306364",
"title": "Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05976802",
"publication_url": "https://clinicaltrials.gov/study/NCT05976802",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236542",
"publication_url": "https://clinicaltrials.gov/study/NCT06236542",
"title": "NextGen Tracheostomy Toolkit: Integrating Augmented and Virtual Reality With Robotics to Improve Tracheostomy Care",
"has_exemption": false,
"start_date": "2027-10-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04071457",
"publication_url": "https://clinicaltrials.gov/study/NCT04071457",
"title": "S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04558736",
"publication_url": "https://clinicaltrials.gov/study/NCT04558736",
"title": "Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561425",
"publication_url": "https://clinicaltrials.gov/study/NCT06561425",
"title": "A Phase I/II, Multicenter Study Evaluating the Feasibility, Safety, and Efficacy of Point-of-care Manufactured GLPG5101 (19CP02) in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Galapagos Cell Therapeutics NV",
"sponsor_slug": "galapagos-cell-therapeutics-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082063",
"publication_url": "https://clinicaltrials.gov/study/NCT06082063",
"title": "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Steno Diabetes Center Copenhagen",
"sponsor_slug": "steno-diabetes-center-copenhagen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364423",
"publication_url": "https://clinicaltrials.gov/study/NCT06364423",
"title": "Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328114",
"publication_url": "https://clinicaltrials.gov/study/NCT06328114",
"title": "Functional Magnetic Resonance Imaging (fMRI)-Guided Individualized Transcranial Magnetic Stimulation (TMS) for Cervical Dystonia",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657976",
"publication_url": "https://clinicaltrials.gov/study/NCT06657976",
"title": "Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06650579",
"publication_url": "https://clinicaltrials.gov/study/NCT06650579",
"title": "Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02916810",
"publication_url": "https://clinicaltrials.gov/study/NCT02916810",
"title": "Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment",
"has_exemption": false,
"start_date": "2025-02-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06427798",
"publication_url": "https://clinicaltrials.gov/study/NCT06427798",
"title": "Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837857",
"publication_url": "https://clinicaltrials.gov/study/NCT06837857",
"title": "Imaging, Cognition, and Opioids in Older Adults With Chronic Pain (I-COAP) Trial",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826859",
"publication_url": "https://clinicaltrials.gov/study/NCT06826859",
"title": "Dose Based Aspirin Pharmacokinetics and Pharmacodynamics in Pregnancy and Association With Pregnancy Outcomes",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013565",
"publication_url": "https://clinicaltrials.gov/study/NCT07013565",
"title": "NYMC623: A Comprehensive Risk-adapted Chemommunotherapy Protocol of Emerging Immunotherapies for Relapsed/Refractory Alk+ Anaplastic Large Cell Lymphoma (ACCELERATE)",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811038",
"publication_url": "https://clinicaltrials.gov/study/NCT06811038",
"title": "Providing Nicotine Replacement Therapy to Enhance the Efficacy of a Smoking Cessation Smartphone App for Hispanic Adults",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05453851",
"publication_url": "https://clinicaltrials.gov/study/NCT05453851",
"title": "Total Pancreatectomy With Islet Cell Autotransplantation in Patients With Benign Pancreatic Neoplasms: A Pilot Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06717347",
"publication_url": "https://clinicaltrials.gov/study/NCT06717347",
"title": "A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221474",
"publication_url": "https://clinicaltrials.gov/study/NCT07221474",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221253",
"publication_url": "https://clinicaltrials.gov/study/NCT07221253",
"title": "Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2029-07-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284745",
"publication_url": "https://clinicaltrials.gov/study/NCT07284745",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06792825",
"publication_url": "https://clinicaltrials.gov/study/NCT06792825",
"title": "HM2023-43: A Phase 2 Trial of Tafasitamab in Combination With Lenalidomide+Rituximab in Treatment-naive Follicular Lymphoma and Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06254482",
"publication_url": "https://clinicaltrials.gov/study/NCT06254482",
"title": "A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2023-08-25",
"completion_date": "2029-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665256",
"publication_url": "https://clinicaltrials.gov/study/NCT06665256",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Refractory Idiopathic Inflammatory Myopathies (IIM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090863",
"publication_url": "https://clinicaltrials.gov/study/NCT07090863",
"title": "Additively (AM) Versus Subtractively (SM) Manufactured Implant Supported Fixed Dental Prostheses (iFDPs)",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2029-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Harvard Medical School (HMS and HSDM)",
"sponsor_slug": "harvard-medical-school-hms-and-hsdm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528496",
"publication_url": "https://clinicaltrials.gov/study/NCT06528496",
"title": "N10: Reduced Therapy for High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-07-22",
"completion_date": "2029-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099391",
"publication_url": "https://clinicaltrials.gov/study/NCT07099391",
"title": "ALTITUDE - ALTernating Induction Therapies to Achieve Undetectable Disease Endpoints: A Phase 1/2 Alternating Dara-RVd/Teclistamab-RVd in Transplant Eligible Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2029-07-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06287775",
"publication_url": "https://clinicaltrials.gov/study/NCT06287775",
"title": "A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2029-07-25",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154745",
"publication_url": "https://clinicaltrials.gov/study/NCT07154745",
"title": "A Single Arm Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Control of Intravascular Hemolysis on Currently Available C5 Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2029-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157892",
"publication_url": "https://clinicaltrials.gov/study/NCT06157892",
"title": "A Phase 1b/2 Open-Label Study of Disitamab Vedotin in Combination With Other Anticancer Therapies in Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Seagen, a wholly owned subsidiary of Pfizer",
"sponsor_slug": "seagen-a-wholly-owned-subsidiary-of-pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097364",
"publication_url": "https://clinicaltrials.gov/study/NCT06097364",
"title": "A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948318",
"publication_url": "https://clinicaltrials.gov/study/NCT06948318",
"title": "A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults With Chronic Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844449",
"publication_url": "https://clinicaltrials.gov/study/NCT05844449",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Year of Age and Older",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06981195",
"publication_url": "https://clinicaltrials.gov/study/NCT06981195",
"title": "Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02307058",
"publication_url": "https://clinicaltrials.gov/study/NCT02307058",
"title": "A Phase II Randomized Trial of MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy - The Miami BLaStM Trial",
"has_exemption": false,
"start_date": "2015-02-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02081326",
"publication_url": "https://clinicaltrials.gov/study/NCT02081326",
"title": "Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02756962",
"publication_url": "https://clinicaltrials.gov/study/NCT02756962",
"title": "Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance",
"has_exemption": false,
"start_date": "2016-07-06",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960022",
"publication_url": "https://clinicaltrials.gov/study/NCT02960022",
"title": "A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study",
"has_exemption": false,
"start_date": "2016-12-22",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04684862",
"publication_url": "https://clinicaltrials.gov/study/NCT04684862",
"title": "Combined Infusion System to Deliver Chemotherapy Regionally to the Liver",
"has_exemption": false,
"start_date": "2021-02-08",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ronald DeMatteo, M.D.",
"sponsor_slug": "ronald-dematteo-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05203172",
"publication_url": "https://clinicaltrials.gov/study/NCT05203172",
"title": "ENCORAFENIB/BINIMETINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05481879",
"publication_url": "https://clinicaltrials.gov/study/NCT05481879",
"title": "A Randomized, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2022-09-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05836987",
"publication_url": "https://clinicaltrials.gov/study/NCT05836987",
"title": "REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation",
"has_exemption": false,
"start_date": "2023-07-13",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05862272",
"publication_url": "https://clinicaltrials.gov/study/NCT05862272",
"title": "A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With Endometriosis",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma Switzerland GmbH",
"sponsor_slug": "sumitomo-pharma-switzerland-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06040255",
"publication_url": "https://clinicaltrials.gov/study/NCT06040255",
"title": "Focal Cerebral Arteriopathy Steroid Trial",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858009",
"publication_url": "https://clinicaltrials.gov/study/NCT04858009",
"title": "A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05806515",
"publication_url": "https://clinicaltrials.gov/study/NCT05806515",
"title": "S2210 A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 Mutations",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328777",
"publication_url": "https://clinicaltrials.gov/study/NCT06328777",
"title": "A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis",
"has_exemption": false,
"start_date": "2024-07-02",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06536413",
"publication_url": "https://clinicaltrials.gov/study/NCT06536413",
"title": "Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06171685",
"publication_url": "https://clinicaltrials.gov/study/NCT06171685",
"title": "A Phase II Randomized Adaptive Platform Trial Evaluating Novel Therapies in Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-17",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734351",
"publication_url": "https://clinicaltrials.gov/study/NCT06734351",
"title": "A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846463",
"publication_url": "https://clinicaltrials.gov/study/NCT06846463",
"title": "Phase 2 Trial Utilizing Zanubrutinib in Patients With Diffuse Large B-cell Lymphoma and MYD88 L265P Mutations, CD79B Mutations, NOTCH1 Truncation or Who Are CD5+ by IHC.",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055581",
"publication_url": "https://clinicaltrials.gov/study/NCT07055581",
"title": "A Phase II Study of Durvalumab Combined With EP Prior to Chemoradiotherapy and Followed by Durvalumab as Consolidation for Patients With Limited-stage Small-cell Lung Cancer (CONCUR Study)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qian Chu",
"sponsor_slug": "qian-chu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665074",
"publication_url": "https://clinicaltrials.gov/study/NCT06665074",
"title": "Inflammatory Challenge in Human Aggression.",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026279",
"publication_url": "https://clinicaltrials.gov/study/NCT07026279",
"title": "A Phase 1b/2a, Multicenter, Open Label Study of the Safety, Efficacy and Pharmacokinetics of Narmafotinib in Combination With Modified FOLFIRINOX in Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amplia Therapeutics Limited",
"sponsor_slug": "amplia-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994442",
"publication_url": "https://clinicaltrials.gov/study/NCT06994442",
"title": "Optimizing Pain Treatment in Children On Mechanical Ventilation",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201207",
"publication_url": "https://clinicaltrials.gov/study/NCT07201207",
"title": "Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satakunta Central Hospital",
"sponsor_slug": "satakunta-central-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325202",
"publication_url": "https://clinicaltrials.gov/study/NCT06325202",
"title": "Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247084",
"publication_url": "https://clinicaltrials.gov/study/NCT07247084",
"title": "A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173803",
"publication_url": "https://clinicaltrials.gov/study/NCT07173803",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217665",
"publication_url": "https://clinicaltrials.gov/study/NCT07217665",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264283",
"publication_url": "https://clinicaltrials.gov/study/NCT07264283",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157033",
"publication_url": "https://clinicaltrials.gov/study/NCT07157033",
"title": "A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xerient Pharma",
"sponsor_slug": "xerient-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227818",
"publication_url": "https://clinicaltrials.gov/study/NCT07227818",
"title": "A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07277309",
"publication_url": "https://clinicaltrials.gov/study/NCT07277309",
"title": "Promoting Recovery After Brain Injury Using Focused Ultrasound",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287449",
"publication_url": "https://clinicaltrials.gov/study/NCT07287449",
"title": "A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dymicron",
"sponsor_slug": "dymicron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07323524",
"publication_url": "https://clinicaltrials.gov/study/NCT07323524",
"title": "Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221214",
"publication_url": "https://clinicaltrials.gov/study/NCT07221214",
"title": "GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV - GL1DER HIV RCT",
"has_exemption": false,
"start_date": "2026-02-06",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285655",
"publication_url": "https://clinicaltrials.gov/study/NCT07285655",
"title": "A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Liquidia Technologies, Inc.",
"sponsor_slug": "liquidia-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02129751",
"publication_url": "https://clinicaltrials.gov/study/NCT02129751",
"title": "A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04539236",
"publication_url": "https://clinicaltrials.gov/study/NCT04539236",
"title": "A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mikkael Sekeres MD",
"sponsor_slug": "mikkael-sekeres-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05377177",
"publication_url": "https://clinicaltrials.gov/study/NCT05377177",
"title": "Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985161",
"publication_url": "https://clinicaltrials.gov/study/NCT05985161",
"title": "A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659381",
"publication_url": "https://clinicaltrials.gov/study/NCT05659381",
"title": "GOG-3068: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Cisplatin Versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients With Homologous Recombinant Deficient (HRD +) Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (Heated Ovarian Treatment Trial)",
"has_exemption": false,
"start_date": "2024-03-08",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032389",
"publication_url": "https://clinicaltrials.gov/study/NCT07032389",
"title": "Polypill Strategy for the Treatment of Patients After Acute Coronary Syndromes - A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819020",
"publication_url": "https://clinicaltrials.gov/study/NCT06819020",
"title": "Adaptive Deep Brain Stimulation to Improve Freezing of Gait in Parkinson's Disease Using Percept RC",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Doris Wang, MD, PhD",
"sponsor_slug": "doris-wang-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704269",
"publication_url": "https://clinicaltrials.gov/study/NCT06704269",
"title": "An Open-label, Multi-center, Phase I/II Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Participants With Treatment-resistant Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-08-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05450705",
"publication_url": "https://clinicaltrials.gov/study/NCT05450705",
"title": "A Phase 3 Open-Label Immunogenicity and Safety Study of 2-Dose Regimens of a 9vHPV Vaccine (V503) in Chinese Girls 9 Through 14 Years of Age With a Comparison to 3-Dose Regimen of V503 in Chinese Women 20 Through 26 Years of Age",
"has_exemption": false,
"start_date": "2022-07-22",
"completion_date": "2029-08-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285460",
"publication_url": "https://clinicaltrials.gov/study/NCT07285460",
"title": "An Open-label, Parallel, Phase 3, Two-arm Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B With or Without Inhibitory Antibodies to Factors VIII or IX",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2029-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285798",
"publication_url": "https://clinicaltrials.gov/study/NCT07285798",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04849871",
"publication_url": "https://clinicaltrials.gov/study/NCT04849871",
"title": "Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2029-08-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03645928",
"publication_url": "https://clinicaltrials.gov/study/NCT03645928",
"title": "A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 144/LN-145/LN-145-S1) in Patients With Solid Tumors",
"has_exemption": false,
"start_date": "2019-05-07",
"completion_date": "2029-08-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07065630",
"publication_url": "https://clinicaltrials.gov/study/NCT07065630",
"title": "A Phase II Study of Volrustomig, Paclitaxel, and Carboplatin Followed by Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer",
"has_exemption": false,
"start_date": "2026-01-17",
"completion_date": "2029-08-13",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184944",
"publication_url": "https://clinicaltrials.gov/study/NCT07184944",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2029-08-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992427",
"publication_url": "https://clinicaltrials.gov/study/NCT06992427",
"title": "High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2029-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07081646",
"publication_url": "https://clinicaltrials.gov/study/NCT07081646",
"title": "A Phase 1b/2 Study of AZD0120 (Also Known as GC012F), a Chimeric Antigen Receptor T Cell Therapy Targeting CD19 and B Cell Maturation Antigen in Participants With Relapsed or Refractory AL Amyloidosis.",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959095",
"publication_url": "https://clinicaltrials.gov/study/NCT06959095",
"title": "A Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab In Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-08-20",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961214",
"publication_url": "https://clinicaltrials.gov/study/NCT06961214",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Depemokimab in Adult Participants With COPD With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635148",
"publication_url": "https://clinicaltrials.gov/study/NCT06635148",
"title": "Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies",
"has_exemption": false,
"start_date": "2024-09-19",
"completion_date": "2029-08-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142343",
"publication_url": "https://clinicaltrials.gov/study/NCT07142343",
"title": "An Open-Label, Single-Arm Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Pozelimab in Pediatric Patients 1 to 5 Years of Age With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2029-08-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03899155",
"publication_url": "https://clinicaltrials.gov/study/NCT03899155",
"title": "Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies",
"has_exemption": false,
"start_date": "2019-08-09",
"completion_date": "2029-08-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04365374",
"publication_url": "https://clinicaltrials.gov/study/NCT04365374",
"title": "A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.",
"has_exemption": false,
"start_date": "2021-04-06",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GT Medical Technologies, Inc.",
"sponsor_slug": "gt-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05485961",
"publication_url": "https://clinicaltrials.gov/study/NCT05485961",
"title": "A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis",
"has_exemption": false,
"start_date": "2022-10-21",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06088290",
"publication_url": "https://clinicaltrials.gov/study/NCT06088290",
"title": "Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PharmaMar",
"sponsor_slug": "pharmamar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07242105",
"publication_url": "https://clinicaltrials.gov/study/NCT07242105",
"title": "Optimized Methods for Measuring Brain Excitability in Depression",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104331",
"publication_url": "https://clinicaltrials.gov/study/NCT07104331",
"title": "SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Alliance for Research through Collaboration",
"sponsor_slug": "sarcoma-alliance-for-research-through-collaboration",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837480",
"publication_url": "https://clinicaltrials.gov/study/NCT06837480",
"title": "Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2029-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03228667",
"publication_url": "https://clinicaltrials.gov/study/NCT03228667",
"title": "QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2018-12-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03737214",
"publication_url": "https://clinicaltrials.gov/study/NCT03737214",
"title": "A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry Disease",
"has_exemption": false,
"start_date": "2018-12-18",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Idorsia Pharmaceuticals Ltd.",
"sponsor_slug": "idorsia-pharmaceuticals-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05071300",
"publication_url": "https://clinicaltrials.gov/study/NCT05071300",
"title": "An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy",
"has_exemption": false,
"start_date": "2022-01-04",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307055",
"publication_url": "https://clinicaltrials.gov/study/NCT05307055",
"title": "Theta Burst Subthalamic Nucleus Deep Brain Stimulation for Cognitive and Motor Improvements in Parkinson's Disease",
"has_exemption": false,
"start_date": "2022-01-11",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05461170",
"publication_url": "https://clinicaltrials.gov/study/NCT05461170",
"title": "A Phase 2 Study to Evaluate Efficacy, Safety and Tolerability of VIR-2218 and VIR-3434 in Participants With Chronic Hepatitis D Virus Infection (SOLSTICE)",
"has_exemption": false,
"start_date": "2022-09-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vir Biotechnology, Inc.",
"sponsor_slug": "vir-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05604131",
"publication_url": "https://clinicaltrials.gov/study/NCT05604131",
"title": "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients",
"has_exemption": false,
"start_date": "2022-11-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rohan Dharmakumar",
"sponsor_slug": "rohan-dharmakumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667493",
"publication_url": "https://clinicaltrials.gov/study/NCT05667493",
"title": "An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (ION-682884) in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05496998",
"publication_url": "https://clinicaltrials.gov/study/NCT05496998",
"title": "Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR Transfemoral System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiovascular",
"sponsor_slug": "medtronic-cardiovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05777993",
"publication_url": "https://clinicaltrials.gov/study/NCT05777993",
"title": "A Rollover Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study",
"has_exemption": false,
"start_date": "2023-07-06",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05838287",
"publication_url": "https://clinicaltrials.gov/study/NCT05838287",
"title": "Pioglitazone, Lipotoxicity, and Heart Failure With Preserved Ejection Fraction (HFpEF)",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06066580",
"publication_url": "https://clinicaltrials.gov/study/NCT06066580",
"title": "An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety, Biomarkers, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-02",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edgewise Therapeutics, Inc.",
"sponsor_slug": "edgewise-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05832229",
"publication_url": "https://clinicaltrials.gov/study/NCT05832229",
"title": "Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364280",
"publication_url": "https://clinicaltrials.gov/study/NCT06364280",
"title": "Pediatric Prehospital Airway Resuscitation Trial",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06219174",
"publication_url": "https://clinicaltrials.gov/study/NCT06219174",
"title": "Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05843253",
"publication_url": "https://clinicaltrials.gov/study/NCT05843253",
"title": "Phase 2 Study of Ribociclib-Containing Post-Radiotherapy Combinations in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma: Ribociclib and Everolimus for HGG/DIPG Which Harbor Alterations of the Cell Cycle and/or PI3K/mTOR Pathways AND Ribociclib and Temozolomide for DHG, H3G34-mutant",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553872",
"publication_url": "https://clinicaltrials.gov/study/NCT06553872",
"title": "A Phase 2, Open-Label, Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492616",
"publication_url": "https://clinicaltrials.gov/study/NCT06492616",
"title": "Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050355",
"publication_url": "https://clinicaltrials.gov/study/NCT07050355",
"title": "Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking (RESTORATION)",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517212",
"publication_url": "https://clinicaltrials.gov/study/NCT06517212",
"title": "Adjuvant Tirzepatide Plus Standard of Care Endocrine Therapy in Patients With Obesity or Overweight Who Have Hormone Receptor-positive, HER2-negative, Node-positive Early Breast Cancer, With Molecular Residual Disease (MRD), as Determined by Circulating Tumor DNA (ctDNA)",
"has_exemption": false,
"start_date": "2024-11-26",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105164",
"publication_url": "https://clinicaltrials.gov/study/NCT06105164",
"title": "Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517888",
"publication_url": "https://clinicaltrials.gov/study/NCT06517888",
"title": "A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma",
"has_exemption": false,
"start_date": "2025-01-17",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780137",
"publication_url": "https://clinicaltrials.gov/study/NCT06780137",
"title": "A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788756",
"publication_url": "https://clinicaltrials.gov/study/NCT06788756",
"title": "A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleculin Biotech, Inc.",
"sponsor_slug": "moleculin-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956300",
"publication_url": "https://clinicaltrials.gov/study/NCT06956300",
"title": "Grit Against Cognitive Decline in Aging and Preclinical Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811233",
"publication_url": "https://clinicaltrials.gov/study/NCT06811233",
"title": "Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902558",
"publication_url": "https://clinicaltrials.gov/study/NCT06902558",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044635",
"publication_url": "https://clinicaltrials.gov/study/NCT07044635",
"title": "Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06993675",
"publication_url": "https://clinicaltrials.gov/study/NCT06993675",
"title": "Improving MRD Negativity Rates in Newly Diagnosed Multiple Myeloma Patients: a Response-adaptive Approach of Consolidation With One or Two Bispecific T-cell Engagers Against GPRC5D or BCMA",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Noffar Bar",
"sponsor_slug": "noffar-bar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06725550",
"publication_url": "https://clinicaltrials.gov/study/NCT06725550",
"title": "Integrative Medicine in Pain Management in Sickle Cell Disease: Assessing the Clinical Efficacy and Neurobiological Impact With Acupuncture, 2.0",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866964",
"publication_url": "https://clinicaltrials.gov/study/NCT06866964",
"title": "A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703216",
"publication_url": "https://clinicaltrials.gov/study/NCT06703216",
"title": "Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ann & Robert H Lurie Children's Hospital of Chicago",
"sponsor_slug": "ann-robert-h-lurie-childrens-hospital-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06629259",
"publication_url": "https://clinicaltrials.gov/study/NCT06629259",
"title": "Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086131",
"publication_url": "https://clinicaltrials.gov/study/NCT07086131",
"title": "Impact Of Adding Inspiratory Muscle Training To Cardiac Rehabilitation On Exercise Responses In Heart Failure",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212114",
"publication_url": "https://clinicaltrials.gov/study/NCT07212114",
"title": "A Randomized, Double-blind, Active Controlled, Single-center Study to Evaluate the Efficacy of EXPAREL vs. Bupivacaine HCl Administered as Combined Sciatic (in the Popliteal Fossa) and Saphenous (in the Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Total Ankle Arthroplasty",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06955169",
"publication_url": "https://clinicaltrials.gov/study/NCT06955169",
"title": "MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RTOG Foundation, Inc.",
"sponsor_slug": "rtog-foundation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223541",
"publication_url": "https://clinicaltrials.gov/study/NCT07223541",
"title": "A Randomized Phase II Trial of Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Oligo-Metastatic Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625073",
"publication_url": "https://clinicaltrials.gov/study/NCT06625073",
"title": "Randomized Trial of Sodium-glucose Cotransporter 2 Inhibition in Heart Transplant Recipients",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201129",
"publication_url": "https://clinicaltrials.gov/study/NCT07201129",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of Cenerimod in Adult Patients With Systemic Lupus Erythematosus and Active Lupus Nephritis in Combination With Background Therapy",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viatris Innovation GmbH",
"sponsor_slug": "viatris-innovation-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222579",
"publication_url": "https://clinicaltrials.gov/study/NCT07222579",
"title": "A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325214",
"publication_url": "https://clinicaltrials.gov/study/NCT07325214",
"title": "A Randomized Pivotal Clinical Trial Evaluating Chemotherapy Regimen Consisting of Irinotecan Hydrochloride, Oxaliplatin, Fluorouracil (5-FU) and Leucovorin With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable Pancreatic Cancer or Locally Advanced Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IMGT Co., Ltd.",
"sponsor_slug": "imgt-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422469",
"publication_url": "https://clinicaltrials.gov/study/NCT05422469",
"title": "Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940570",
"publication_url": "https://clinicaltrials.gov/study/NCT06940570",
"title": "A Randomized Single Center Trial to Determine the Efficacy of Methadone as a First Line Agent in the Reduction and Treatment of Pain in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2028-01-01",
"completion_date": "2029-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05963698",
"publication_url": "https://clinicaltrials.gov/study/NCT05963698",
"title": "The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4)",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06586021",
"publication_url": "https://clinicaltrials.gov/study/NCT06586021",
"title": "SEAL - Safety & Feasibility Evaluation of the Aortoseal™ for Seal and Fixation of Abdominal Aortic Aneurysms (AAA) Endovascular Grafts to the Aortic Wall\"",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endoron Medical",
"sponsor_slug": "endoron-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722391",
"publication_url": "https://clinicaltrials.gov/study/NCT06722391",
"title": "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas, El Paso",
"sponsor_slug": "university-of-texas-el-paso",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525740",
"publication_url": "https://clinicaltrials.gov/study/NCT06525740",
"title": "Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06580041",
"publication_url": "https://clinicaltrials.gov/study/NCT06580041",
"title": "Precision Care for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483061",
"publication_url": "https://clinicaltrials.gov/study/NCT06483061",
"title": "Ferumoxytol Enhanced Hippocampal Vascular Imaging in Epilepsy",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949423",
"publication_url": "https://clinicaltrials.gov/study/NCT06949423",
"title": "Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06645613",
"publication_url": "https://clinicaltrials.gov/study/NCT06645613",
"title": "Precision TMS With Integrated Visualization and Analysis of Real-time E-field and EEG Source Imaging",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855433",
"publication_url": "https://clinicaltrials.gov/study/NCT06855433",
"title": "A Randomized, Double-Blind, Multi-Site Placebo Controlled Trial of Colchicine in Calcium Pyrophosphate Deposition Disease",
"has_exemption": false,
"start_date": "2026-04-10",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313891",
"publication_url": "https://clinicaltrials.gov/study/NCT07313891",
"title": "A Phase 3, Randomized Study Evaluating the Efficacy and Safety of NDV-01 Versus Observation in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (BOOST)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Relmada Therapeutics, Inc.",
"sponsor_slug": "relmada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187375",
"publication_url": "https://clinicaltrials.gov/study/NCT07187375",
"title": "A Phase 2, Open-Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Crinecerfont in Pediatric Subjects 0 to <2 Years of Age With Congenital Adrenal Hyperplasia",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04994717",
"publication_url": "https://clinicaltrials.gov/study/NCT04994717",
"title": "Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827081",
"publication_url": "https://clinicaltrials.gov/study/NCT05827081",
"title": "A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER)",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875310",
"publication_url": "https://clinicaltrials.gov/study/NCT06875310",
"title": "A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282613",
"publication_url": "https://clinicaltrials.gov/study/NCT07282613",
"title": "Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-08-04",
"completion_date": "2029-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06469944",
"publication_url": "https://clinicaltrials.gov/study/NCT06469944",
"title": "A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C",
"has_exemption": false,
"start_date": "2024-09-20",
"completion_date": "2029-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714202",
"publication_url": "https://clinicaltrials.gov/study/NCT05714202",
"title": "A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2029-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04123795",
"publication_url": "https://clinicaltrials.gov/study/NCT04123795",
"title": "Multicenter, Open Label or Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Pediatric Study Participants With Moderate to Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2029-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04794101",
"publication_url": "https://clinicaltrials.gov/study/NCT04794101",
"title": "Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2029-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024394",
"publication_url": "https://clinicaltrials.gov/study/NCT07024394",
"title": "A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Ruvometinib Tablets (FCN-159 Tablets) in Pediatric Participants With Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.",
"sponsor_slug": "shanghai-fosun-pharmaceutical-industrial-development-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04802603",
"publication_url": "https://clinicaltrials.gov/study/NCT04802603",
"title": "Dose-Escalated Spine SbRT (DESSRT) for Localized Metastasis to the Spinal Column",
"has_exemption": false,
"start_date": "2021-03-14",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02915198",
"publication_url": "https://clinicaltrials.gov/study/NCT02915198",
"title": "CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2029-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00781612",
"publication_url": "https://clinicaltrials.gov/study/NCT00781612",
"title": "An Open-Label, Multicenter Extension Study of Trastuzumab Emtansine Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd-Sponsored Trastuzumab Emtansine Study",
"has_exemption": false,
"start_date": "2008-10-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03770572",
"publication_url": "https://clinicaltrials.gov/study/NCT03770572",
"title": "Phase I/IIa Gene Transfer Clinical Trial for Juvenile Neuronal Ceroid Lipofuscinosis, Delivering the CLN3 Gene by Self-Complementary AAV9",
"has_exemption": false,
"start_date": "2018-11-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alcyone Therapeutics, Inc",
"sponsor_slug": "alcyone-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05374590",
"publication_url": "https://clinicaltrials.gov/study/NCT05374590",
"title": "A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05445323",
"publication_url": "https://clinicaltrials.gov/study/NCT05445323",
"title": "A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lexeo Therapeutics",
"sponsor_slug": "lexeo-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05489887",
"publication_url": "https://clinicaltrials.gov/study/NCT05489887",
"title": "A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409989",
"publication_url": "https://clinicaltrials.gov/study/NCT05409989",
"title": "MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Microvention-Terumo, Inc.",
"sponsor_slug": "microvention-terumo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05405361",
"publication_url": "https://clinicaltrials.gov/study/NCT05405361",
"title": "A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy",
"has_exemption": false,
"start_date": "2023-01-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05633667",
"publication_url": "https://clinicaltrials.gov/study/NCT05633667",
"title": "A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05467670",
"publication_url": "https://clinicaltrials.gov/study/NCT05467670",
"title": "Safety and Efficacy of Anti-CD47, ALX148 in Combination with Liposomal Doxorubicin and Pembrolizumab in Patients with Recurrent Platinum-resistant Ovarian Cancer: Phase II Study",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexander B Olawaiye, MD",
"sponsor_slug": "alexander-b-olawaiye-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526144",
"publication_url": "https://clinicaltrials.gov/study/NCT05526144",
"title": "Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05891821",
"publication_url": "https://clinicaltrials.gov/study/NCT05891821",
"title": "Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465745",
"publication_url": "https://clinicaltrials.gov/study/NCT06465745",
"title": "AltaValve Pivotal Trial",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "4C Medical Technologies, Inc.",
"sponsor_slug": "4c-medical-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528314",
"publication_url": "https://clinicaltrials.gov/study/NCT06528314",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrohosis Due to NASH/MASH",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akero Therapeutics, Inc",
"sponsor_slug": "akero-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657859",
"publication_url": "https://clinicaltrials.gov/study/NCT06657859",
"title": "A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants With PMM2-CDG",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Glycomine, Inc.",
"sponsor_slug": "glycomine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095205",
"publication_url": "https://clinicaltrials.gov/study/NCT07095205",
"title": "Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06557512",
"publication_url": "https://clinicaltrials.gov/study/NCT06557512",
"title": "A Pilot Trial of Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma (SRS-AIM)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526195",
"publication_url": "https://clinicaltrials.gov/study/NCT06526195",
"title": "Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06359041",
"publication_url": "https://clinicaltrials.gov/study/NCT06359041",
"title": "RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406452",
"publication_url": "https://clinicaltrials.gov/study/NCT06406452",
"title": "A Multi-Center Trial to Assess the Safety and Effectiveness of a Bioresorbable Tracheobronchial Splint in Pediatric Subjects With Clinically Significant Tracheobronchomalacia",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06493552",
"publication_url": "https://clinicaltrials.gov/study/NCT06493552",
"title": "A Modular, Open Label, Randomized Phase II/III Trial to Assess Efficacy of Combining sEphB4-HSA (EphrinB2 Inhibitor) With Immunotherapy Regimens in Patients With EphrinB2-High Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasgene Therapeutics, Inc",
"sponsor_slug": "vasgene-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553885",
"publication_url": "https://clinicaltrials.gov/study/NCT06553885",
"title": "A Phase II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic Colorectal Cancer or Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943872",
"publication_url": "https://clinicaltrials.gov/study/NCT06943872",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-06-11",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151677",
"publication_url": "https://clinicaltrials.gov/study/NCT07151677",
"title": "Pre-Frontal tDCS as a Novel Intervention to Reduce Effects of Post-Stroke Fatigue While Improving Language and Attention in Aphasia",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syracuse University",
"sponsor_slug": "syracuse-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011771",
"publication_url": "https://clinicaltrials.gov/study/NCT07011771",
"title": "A Phase 1/2 Dose-Escalation Trial to Evaluate Safety, Tolerability, and Efficacy of a Single Dose of CAP-003 Gene Therapy Administered to Patients With Parkinson's Disease With GBA1 Gene Mutation (PD-GBA)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Capsida Biotherapeutics, Inc.",
"sponsor_slug": "capsida-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145255",
"publication_url": "https://clinicaltrials.gov/study/NCT07145255",
"title": "A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MBrace Therapeutics",
"sponsor_slug": "mbrace-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091734",
"publication_url": "https://clinicaltrials.gov/study/NCT07091734",
"title": "Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07140679",
"publication_url": "https://clinicaltrials.gov/study/NCT07140679",
"title": "A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151248",
"publication_url": "https://clinicaltrials.gov/study/NCT07151248",
"title": "ELECTRIG: Evaluating Effects of Cranial Electrical Stimulation Therapy With Responsive Imaging in Gulf War Illness Pain and Comorbid Symptoms",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198529",
"publication_url": "https://clinicaltrials.gov/study/NCT07198529",
"title": "Optical Coherence Tomography for Stent Optimization and Its Impact on Short-Duration Dual Antiplatelet Therapy: A Single-Center, Prospective, Exploratory Study",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Korea University Guro Hospital",
"sponsor_slug": "korea-university-guro-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178145",
"publication_url": "https://clinicaltrials.gov/study/NCT07178145",
"title": "MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933706",
"publication_url": "https://clinicaltrials.gov/study/NCT06933706",
"title": "Losartan to Improve Outcomes After Multi-ligament Knee Injury",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104916",
"publication_url": "https://clinicaltrials.gov/study/NCT07104916",
"title": "A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Anthony P King",
"sponsor_slug": "anthony-p-king",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191327",
"publication_url": "https://clinicaltrials.gov/study/NCT07191327",
"title": "Testing Personalized High Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06274112",
"publication_url": "https://clinicaltrials.gov/study/NCT06274112",
"title": "Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Auburn University",
"sponsor_slug": "auburn-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284784",
"publication_url": "https://clinicaltrials.gov/study/NCT07284784",
"title": "An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Annovis Bio Inc.",
"sponsor_slug": "annovis-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05842174",
"publication_url": "https://clinicaltrials.gov/study/NCT05842174",
"title": "Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional Therapy",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07088120",
"publication_url": "https://clinicaltrials.gov/study/NCT07088120",
"title": "PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07230288",
"publication_url": "https://clinicaltrials.gov/study/NCT07230288",
"title": "A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660225",
"publication_url": "https://clinicaltrials.gov/study/NCT06660225",
"title": "Towards Closed Loop Deep Brain Stimulation for Treatment of Refractory Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Pouratian",
"sponsor_slug": "nader-pouratian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219459",
"publication_url": "https://clinicaltrials.gov/study/NCT07219459",
"title": "A Phase 2b, Randomized, Blinded Trial Investigating the Efficacy and Safety of Visugromab in Combination With Nivolumab and a Tyrosine Kinase Inhibitor Compared to Double Placebo and a Tyrosine Kinase Inhibitor in Participants With Unresectable or Metastatic Hepatocellular Carcinoma and Compensated Liver Function (Child-Pugh A) After Failure of First-Line Treatment That Included an Anti PD-(L)1 Compound (GDFATHER HCC-01)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465706",
"publication_url": "https://clinicaltrials.gov/study/NCT06465706",
"title": "A Prospective, Multicenter, Randomized Controlled Trial Assessing the Safety and Efficacy of the LAmbre™ Plus Left Atrial Appendage Closure System to REDUCE the Risk of Thromboembolism in Patients With Non-Valvular Atrial Fibrillation",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kansas City Heart Rhythm Research Foundation",
"sponsor_slug": "kansas-city-heart-rhythm-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06306638",
"publication_url": "https://clinicaltrials.gov/study/NCT06306638",
"title": "A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients With Inoperable Malignant Central Airway Obstruction",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548113",
"publication_url": "https://clinicaltrials.gov/study/NCT06548113",
"title": "Investigation of Sensory Synchronized Human Brain Imaging and Neuromodulation",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05956821",
"publication_url": "https://clinicaltrials.gov/study/NCT05956821",
"title": "Phase I/II Trial of Repeat Dosing of Super-Selective Intraarterial Infusion of Erbitux (Cetuximab) and Avastin (Bevacizumab) for Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age",
"has_exemption": false,
"start_date": "2025-06-19",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07246863",
"publication_url": "https://clinicaltrials.gov/study/NCT07246863",
"title": "Ph 2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab and Nivolumab With or Without Docetaxel Versus Docetaxel in 2L Treatment of Participants With Metastatic NSCLC (GDFATHER-NSCLC-02)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128199",
"publication_url": "https://clinicaltrials.gov/study/NCT07128199",
"title": "A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Oncology, Inc.",
"sponsor_slug": "taiho-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05935761",
"publication_url": "https://clinicaltrials.gov/study/NCT05935761",
"title": "Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283705",
"publication_url": "https://clinicaltrials.gov/study/NCT07283705",
"title": "A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06093425",
"publication_url": "https://clinicaltrials.gov/study/NCT06093425",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating Combination of TST001, Pembrolizumab and Chemotherapy as First-Line Treatment in Subjects With Claudin18.2 Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Suzhou Transcenta Therapeutics Co., Ltd.",
"sponsor_slug": "suzhou-transcenta-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04871607",
"publication_url": "https://clinicaltrials.gov/study/NCT04871607",
"title": "A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115043",
"publication_url": "https://clinicaltrials.gov/study/NCT07115043",
"title": "A Phase I/II Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6750, a CD8 Guided IL-2 Agent Alone and in Combination With Other Anti-cancer Agents in Participants With Select Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2029-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859099",
"publication_url": "https://clinicaltrials.gov/study/NCT06859099",
"title": "Long-term Extension Study to Evaluate the Safety and Efficacy of Riliprubart (SAR445088) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07266831",
"publication_url": "https://clinicaltrials.gov/study/NCT07266831",
"title": "A Phase 2/3, Randomized, Active-Controlled, Open-Label (Phase 2) and Double-Blind (Phase 3) Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Once Daily in Treatment-Naïve Adult Participants Living With HIV-1",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2029-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06667726",
"publication_url": "https://clinicaltrials.gov/study/NCT06667726",
"title": "A Centralized Protocol Evaluating the Safety and Clinical Impact of Amino Acid Pet for Brain Tumors",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-10-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03552016",
"publication_url": "https://clinicaltrials.gov/study/NCT03552016",
"title": "Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure",
"has_exemption": false,
"start_date": "2018-10-10",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848088",
"publication_url": "https://clinicaltrials.gov/study/NCT06848088",
"title": "Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613",
"has_exemption": false,
"start_date": "2025-04-14",
"completion_date": "2029-10-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979453",
"publication_url": "https://clinicaltrials.gov/study/NCT06979453",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04908709",
"publication_url": "https://clinicaltrials.gov/study/NCT04908709",
"title": "Spectroscopic MRI Guided Proton Therapy for Pediatric High-Grade Glioma (RAD4500)",
"has_exemption": false,
"start_date": "2018-12-20",
"completion_date": "2029-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291076",
"publication_url": "https://clinicaltrials.gov/study/NCT07291076",
"title": "ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2029-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428409",
"publication_url": "https://clinicaltrials.gov/study/NCT06428409",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2029-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04094090",
"publication_url": "https://clinicaltrials.gov/study/NCT04094090",
"title": "Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia",
"has_exemption": false,
"start_date": "2019-10-19",
"completion_date": "2029-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Goodman Eye Center",
"sponsor_slug": "goodman-eye-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194980",
"publication_url": "https://clinicaltrials.gov/study/NCT07194980",
"title": "Safety and Efficacy of the Addition of Nemtabrutinib to Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04708041",
"publication_url": "https://clinicaltrials.gov/study/NCT04708041",
"title": "A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen With Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared With a Standard 3-dose Regimen in 16- to 26-Year Old Women",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04144972",
"publication_url": "https://clinicaltrials.gov/study/NCT04144972",
"title": "Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain Using Summit RC+S",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2029-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933577",
"publication_url": "https://clinicaltrials.gov/study/NCT05933577",
"title": "A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma (INTerpath-001)",
"has_exemption": false,
"start_date": "2023-07-19",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000357",
"publication_url": "https://clinicaltrials.gov/study/NCT07000357",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07206056",
"publication_url": "https://clinicaltrials.gov/study/NCT07206056",
"title": "TulmiSTAR-01: A Two-part, Phase I Dose Escalation and Expansion Followed by a Randomized, Open-label Multicenter, Phase II Study to Assess the Safety and Efficacy of the Combination of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) vs Standard of Care in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2029-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04419649",
"publication_url": "https://clinicaltrials.gov/study/NCT04419649",
"title": "A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)",
"has_exemption": false,
"start_date": "2020-08-19",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05187338",
"publication_url": "https://clinicaltrials.gov/study/NCT05187338",
"title": "Triplex CTLA4/PD1/PDL1 Checkpoint Inhibitors Combination Therapy for Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-11-01",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04743661",
"publication_url": "https://clinicaltrials.gov/study/NCT04743661",
"title": "Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients With Recurrent Medulloblastoma and Ependymoma",
"has_exemption": false,
"start_date": "2022-04-04",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513962",
"publication_url": "https://clinicaltrials.gov/study/NCT06513962",
"title": "Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342478",
"publication_url": "https://clinicaltrials.gov/study/NCT07342478",
"title": "A Phase 3 Open-Label, Randomized, Multicenter Study of Rocbrutinib (LP-168) vs Pirtobrutinib in Covalent BTK Inhibitor (cBTKi) Pretreated Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Subjects",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Newave Pharmaceutical Inc",
"sponsor_slug": "newave-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00887146",
"publication_url": "https://clinicaltrials.gov/study/NCT00887146",
"title": "Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma",
"has_exemption": false,
"start_date": "2009-09-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03683251",
"publication_url": "https://clinicaltrials.gov/study/NCT03683251",
"title": "A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)",
"has_exemption": false,
"start_date": "2018-09-20",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04587128",
"publication_url": "https://clinicaltrials.gov/study/NCT04587128",
"title": "Phase II Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05894343",
"publication_url": "https://clinicaltrials.gov/study/NCT05894343",
"title": "Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease",
"has_exemption": false,
"start_date": "2023-05-19",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx, LLC",
"sponsor_slug": "meiragtx-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800743",
"publication_url": "https://clinicaltrials.gov/study/NCT05800743",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649539",
"publication_url": "https://clinicaltrials.gov/study/NCT06649539",
"title": "Efficacy of a Step-wise Protocol in Optimizing CCH Outcomes in Men With Peyronie's Disease",
"has_exemption": false,
"start_date": "2024-10-11",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619561",
"publication_url": "https://clinicaltrials.gov/study/NCT06619561",
"title": "A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558214",
"publication_url": "https://clinicaltrials.gov/study/NCT06558214",
"title": "OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789445",
"publication_url": "https://clinicaltrials.gov/study/NCT06789445",
"title": "A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueRock Therapeutics",
"sponsor_slug": "bluerock-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635889",
"publication_url": "https://clinicaltrials.gov/study/NCT06635889",
"title": "Double-Blind Randomized Placebo Controlled Trial of Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801834",
"publication_url": "https://clinicaltrials.gov/study/NCT06801834",
"title": "A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577714",
"publication_url": "https://clinicaltrials.gov/study/NCT06577714",
"title": "Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990867",
"publication_url": "https://clinicaltrials.gov/study/NCT06990867",
"title": "Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke With Late Presentations",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corxel Pharmaceuticals",
"sponsor_slug": "corxel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06418178",
"publication_url": "https://clinicaltrials.gov/study/NCT06418178",
"title": "A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. Veterans",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bronx VA Medical Center",
"sponsor_slug": "bronx-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909565",
"publication_url": "https://clinicaltrials.gov/study/NCT06909565",
"title": "Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639282",
"publication_url": "https://clinicaltrials.gov/study/NCT06639282",
"title": "SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer&Amp;#39;s Disease Dementia",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Joseph's Hospital and Medical Center, Phoenix",
"sponsor_slug": "st-josephs-hospital-and-medical-center-phoenix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160179",
"publication_url": "https://clinicaltrials.gov/study/NCT07160179",
"title": "Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of ABBV-6628 in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975111",
"publication_url": "https://clinicaltrials.gov/study/NCT06975111",
"title": "Focusing on the Menopausal Transition to Improve Mid-Life Women's Health",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06718751",
"publication_url": "https://clinicaltrials.gov/study/NCT06718751",
"title": "Tranexamic Acid Therapy For The Treatment of Subdural Hematomas",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193550",
"publication_url": "https://clinicaltrials.gov/study/NCT07193550",
"title": "A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218380",
"publication_url": "https://clinicaltrials.gov/study/NCT07218380",
"title": "FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213960",
"publication_url": "https://clinicaltrials.gov/study/NCT07213960",
"title": "A Sequential Phase 2/3, Single-Arm, Open-Label Study in Adults Followed by a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of APL2 in Adults and Adolescents With Focal Segmental Glomerulosclerosis",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apellis Pharmaceuticals, Inc.",
"sponsor_slug": "apellis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07175051",
"publication_url": "https://clinicaltrials.gov/study/NCT07175051",
"title": "Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06898970",
"publication_url": "https://clinicaltrials.gov/study/NCT06898970",
"title": "An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Varun Monga, MBBS",
"sponsor_slug": "varun-monga-mbbs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07077395",
"publication_url": "https://clinicaltrials.gov/study/NCT07077395",
"title": "Finding Links Between Hot flASHes and CardioVascular Disease",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697496",
"publication_url": "https://clinicaltrials.gov/study/NCT06697496",
"title": "Navigation and Artificial Intelligence Technology for Indigenous Virtual Education on Smoking Cessation (NAITIVE)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07368985",
"publication_url": "https://clinicaltrials.gov/study/NCT07368985",
"title": "A Phase II Single Arm Open Label Study of Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer: an EMBRACE High Risk Study Initiative",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof. Dr. Remi A. Nout",
"sponsor_slug": "prof-dr-remi-a-nout",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04865939",
"publication_url": "https://clinicaltrials.gov/study/NCT04865939",
"title": "A Randomized Trial Comparing Intravesical Gemcitabine to Continuous Bladder Irrigation With Sterile Water to Prevent Bladder Cancer Implantation in Patients Undergoing Excision of Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2021-11-29",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05538663",
"publication_url": "https://clinicaltrials.gov/study/NCT05538663",
"title": "A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE)",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854003",
"publication_url": "https://clinicaltrials.gov/study/NCT06854003",
"title": "A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christine Ryan",
"sponsor_slug": "christine-ryan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07147816",
"publication_url": "https://clinicaltrials.gov/study/NCT07147816",
"title": "Effects of Transcutaneous Cervical Spinal Cord Stimulation on Upper Limb Motor Function After Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roberto de Freitas",
"sponsor_slug": "roberto-de-freitas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115940",
"publication_url": "https://clinicaltrials.gov/study/NCT07115940",
"title": "Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well - SELECT LATE Trial",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Amrou Sarraj",
"sponsor_slug": "amrou-sarraj",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07269470",
"publication_url": "https://clinicaltrials.gov/study/NCT07269470",
"title": "Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07177339",
"publication_url": "https://clinicaltrials.gov/study/NCT07177339",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study of the Efficacy and Safety of Early Depemokimab Initiation as add-on Treatment in COPD Patients With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2029-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06698003",
"publication_url": "https://clinicaltrials.gov/study/NCT06698003",
"title": "A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1",
"has_exemption": false,
"start_date": "2024-11-15",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052942",
"publication_url": "https://clinicaltrials.gov/study/NCT07052942",
"title": "Individualizing Treatment for Asthma in Primary Care (Full Study)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "DARTNet Institute",
"sponsor_slug": "dartnet-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220083",
"publication_url": "https://clinicaltrials.gov/study/NCT07220083",
"title": "A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants",
"has_exemption": false,
"start_date": "2026-01-23",
"completion_date": "2029-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05526755",
"publication_url": "https://clinicaltrials.gov/study/NCT05526755",
"title": "An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2029-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05636618",
"publication_url": "https://clinicaltrials.gov/study/NCT05636618",
"title": "A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2029-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190209",
"publication_url": "https://clinicaltrials.gov/study/NCT07190209",
"title": "A Phase 2b/3, Randomized, Double-blind, Placebocontrolled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190222",
"publication_url": "https://clinicaltrials.gov/study/NCT07190222",
"title": "A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2029-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293351",
"publication_url": "https://clinicaltrials.gov/study/NCT07293351",
"title": "ROSETTA RCC-208: A Phase 1/2 Open-label, Multi-center, Randomized Study of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2029-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06008756",
"publication_url": "https://clinicaltrials.gov/study/NCT06008756",
"title": "Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2023-10-09",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187401",
"publication_url": "https://clinicaltrials.gov/study/NCT07187401",
"title": "A Randomized, Double-Blind, Placebo-Controlled, First-In-Human Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ALN-CFB, an Investigational siRNA Therapeutic Against Complement Factor B, in Participants With Paroxysmal Nocturnal Hemoglobinuria and Persistent Anemia on Approved C5-Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769766",
"publication_url": "https://clinicaltrials.gov/study/NCT03769766",
"title": "A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance",
"has_exemption": false,
"start_date": "2019-03-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05524883",
"publication_url": "https://clinicaltrials.gov/study/NCT05524883",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-251 Administered to Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping",
"has_exemption": false,
"start_date": "2022-08-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03762395",
"publication_url": "https://clinicaltrials.gov/study/NCT03762395",
"title": "Anti Inflammatory Lipid Mediators in Asthma: A Double Blind Placebo Control Cross Over, Proof of Concept Study of CXA-10 to Reduce Bronchial Hyperresponsiveness in Obese Asthmatics; Lipid Anti-Inflammatory Mediators in Asthma to Reduce Hyperresponsiveness in Obese Asthmatics",
"has_exemption": false,
"start_date": "2023-02-08",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06163430",
"publication_url": "https://clinicaltrials.gov/study/NCT06163430",
"title": "A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-03-26",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Terns, Inc.",
"sponsor_slug": "terns-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796908",
"publication_url": "https://clinicaltrials.gov/study/NCT05796908",
"title": "A Prospective, Multi-Center, Single-Arm Clinical Trial of the Safety and Effectiveness of the Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.",
"has_exemption": false,
"start_date": "2024-04-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Aptis Medical",
"sponsor_slug": "aptis-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998031",
"publication_url": "https://clinicaltrials.gov/study/NCT05998031",
"title": "A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients",
"has_exemption": false,
"start_date": "2024-04-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951906",
"publication_url": "https://clinicaltrials.gov/study/NCT06951906",
"title": "Imaging Biomarkers of Freezing of Gait Response to Deep Brain Stimulation",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399263",
"publication_url": "https://clinicaltrials.gov/study/NCT06399263",
"title": "Study of Psilocybin for Anorexia in Young Adults",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marissa Raymond-Flesch, MD, MPH",
"sponsor_slug": "marissa-raymond-flesch-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06589804",
"publication_url": "https://clinicaltrials.gov/study/NCT06589804",
"title": "Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668493",
"publication_url": "https://clinicaltrials.gov/study/NCT06668493",
"title": "A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ferring Pharmaceuticals",
"sponsor_slug": "ferring-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023289",
"publication_url": "https://clinicaltrials.gov/study/NCT07023289",
"title": "A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects With Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07069738",
"publication_url": "https://clinicaltrials.gov/study/NCT07069738",
"title": "Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07207369",
"publication_url": "https://clinicaltrials.gov/study/NCT07207369",
"title": "A Multicenter, Cohort-design, Double-blind, Randomized, Parallel-group, Controlled Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095868",
"publication_url": "https://clinicaltrials.gov/study/NCT07095868",
"title": "A Phase I/IIa Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Solid Tumors",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Everest Medicines (Beijing) Co., Ltd.",
"sponsor_slug": "everest-medicines-beijing-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188805",
"publication_url": "https://clinicaltrials.gov/study/NCT07188805",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Investigate the Efficacy, Safety, and PK/ PD of Finerenone, in Addition to Standard-of-care, in Pediatric Patients, 6 Months to < 18 Years of Age With Heart Failure (HF) and Left Ventricular Systolic Dysfunction (LVSD)",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07171489",
"publication_url": "https://clinicaltrials.gov/study/NCT07171489",
"title": "An Early Feasibility Study of Using the AccelBand, a Leg-worn Transcutaneous Neuromodulation (TNM) Device, for Neurogenic Bowel Dysfunction (NBD) in People With Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179315",
"publication_url": "https://clinicaltrials.gov/study/NCT07179315",
"title": "A Randomized Phase II Trial of Cemiplimab With or Without Fianlimab in Patients With Detectable Minimal-residual Disease After Definitive Treatment for Human Papillomavirus Positive HPV(+) Head and Neck Cancer.",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}